Nimodipine in acute ischemic stroke: a double-blind controlled study
Authors:
- L. SantisLSL. Santis
- G. LanciaGLG. Lancia
- 1 October 1989
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 80 (4) , 282-286
Abstract
— Nimodipine (BAY e 9736), a new dihydropyridine derivative, has been shown to reduce neurological deficits and mortality induced by acute cerebral ischemia in experimental studies. We investigated the effects of this calcium antagonist in patients with acute ischemic stroke through a randomized, double‐blind, parallel‐designed trial in which nimodipine was compared with placebo. Forty‐one of 54 screened cases were found to fulfil the inclusion criteria (sudden occurrence of a focal neurological deficit secondary to an acute ischemic event in the carotid area diagnosed after a complete neurological work‐up) and entered the study. Nineteen of them were treated with nimodipine (40 mg t.i.d. administered for 28 days) and the remaining 22 with placebo, given in identical tablets. In all patients the treatment started within 12 h after the onset of the symptoms. Course and intensity of the neurological deficit were evaluated by the Mathew Scale (slightly modified). Forty patients concluded the trial. Nimodipine was withdrawn in one case following the occurrence of a skin rash whose causative relation with the test drug could not be clarified. Altogether, however, nimodipine was well tolerated and no severe cardiovascular adverse reactions were observed. In terms of efficacy, the scores obtained by the Mathew Scale showed a higher rate of improvement on nimodipine than on placebo, thus indicating that patients receiving the latter drug did not fare as well as those receiving the test medication. Our data suggest that nimodipine may be beneficial in the treatment of acute stroke.Keywords
This publication has 9 references indexed in Scilit:
- A Controlled Trial of Nimodipine in Acute Ischemic StrokeNew England Journal of Medicine, 1988
- Effect of pretreatment with the calcium antagonist nimodipine on local cerebral blood flow and histopathology after middle cerebral artery occlusionAnnals of Neurology, 1985
- The effects of nimodipine on the clinical course of patients with acute ischemic strokeActa Neurologica Scandinavica, 1984
- Cerebral Blood Flow and Neurologic Outcome When Nimodipine is Given after Complete Cerebral Ischemia in the DogJournal of Cerebral Blood Flow & Metabolism, 1984
- Nimodipine Improves Cerebral Blood Flow and Neurologic Recovery after Complete Cerebral Ischemia in the DogJournal of Cerebral Blood Flow & Metabolism, 1983
- Effect of glycerol treatment on the natural history of acute cerebral infarctionClinical Neurology and Neurosurgery, 1975
- DOUBLE-BLIND EVALUATION OF GLYCEROL THERAPY IN ACUTE CEREBRAL INFARCTIONThe Lancet, 1972
- Morphological Changes of Heart Muscle Caused by Successive Perfusion with Calcium-free and Calcium-containing Solutions (Calcium Paradox)Cardiovascular Research, 1967
- On Methods in the Analysis of Profile DataPsychometrika, 1959